Question
A 4 years child presented with history of fever, neck rigidity and altered sensorium for the last 48 hours. He was admitted in the hospital for evaluation. CSF was collected and examined for cell morphology, protein and sugar. Answer the following: What is the probable diagnosis. Name the bacterial etiologic agents causing this condition. How will you proceed with the lab. diagnosis. What are the virulence factors associated with this and describe the pathogenesis What measures can you take to prevent this condition. (1+2+3+3+1)
Answer
Probable diagnosis: Acute bacterial (pyogenic) meningitis — fever, neck rigidity, and altered sensorium in a young child, with CSF sent for cell count/differential, protein, and glucose, is the classical presentation and work-up.
Bacterial etiologic agents (varies by age group, but for this age range): Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b are the classical agents in children beyond the neonatal period; Escherichia coli and Group B Streptococcus are more typical in neonates.
Laboratory diagnosis
- CSF examination: typically shows raised opening pressure, turbid/cloudy appearance, neutrophilic pleocytosis (high white cell count, predominantly neutrophils), raised protein, and markedly reduced glucose (low CSF:blood glucose ratio) in bacterial meningitis — distinguishing it from the lymphocytic pleocytosis with normal glucose typical of viral meningitis.
- Gram stain of CSF (after centrifugation/cytospin) — rapid presumptive identification: Gram-positive diplococci (S. pneumoniae), Gram-negative diplococci (N. meningitidis), or small Gram-negative coccobacilli (H. influenzae).
- CSF culture — the definitive diagnostic test; CSF plated on blood agar and chocolate agar, incubated in a CO2-enriched atmosphere; also allows antibiotic susceptibility testing.
- Latex agglutination test — rapid detection of bacterial capsular antigen directly in CSF, useful when the patient has already received antibiotics (culture may then be negative/falsely sterile).
- Blood culture — often positive concurrently, since bacterial meningitis is usually preceded by bacteraemia.
- PCR — increasingly used for rapid, sensitive detection, particularly useful after antibiotics have been started.
Virulence factors and pathogenesis: the key shared virulence factor among the major meningeal pathogens is a polysaccharide capsule, which is antiphagocytic, allowing the organism to survive in blood and evade clearance, facilitating bacteraemia and subsequent haematogenous spread to the meninges; other adhesins (e.g., pili in N. meningitidis) mediate attachment to nasopharyngeal/choroid plexus epithelium; once the organism crosses the blood-brain/blood-CSF barrier, bacterial cell wall components (peptidoglycan, LPS/endotoxin in Gram-negative organisms) trigger a marked host inflammatory response (release of TNF-α, IL-1, IL-6), which drives the increased blood-brain barrier permeability, cerebral oedema, raised intracranial pressure, and neuronal injury responsible for much of the clinical severity and neurological sequelae — the host inflammatory response, not just direct bacterial invasion, is a major contributor to damage.
Preventive measures: vaccination — conjugate vaccines against S. pneumoniae (PCV), H. influenzae type b (Hib, part of pentavalent/DPT-based schedules), and N. meningitidis (meningococcal conjugate vaccine); chemoprophylaxis (rifampicin or ciprofloxacin) for close contacts of meningococcal meningitis cases; prompt treatment of upper respiratory tract infections and early recognition/treatment of suspected meningitis to reduce transmission and complications.